These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10867102)

  • 1. Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure.
    Oya H; Nagaya N; Furuichi S; Nishikimi T; Ueno K; Nakanishi N; Yamagishi M; Kangawa K; Miyatake K
    Am J Cardiol; 2000 Jul; 86(1):94-8. PubMed ID: 10867102
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
    Connelly TP; Francis GS; Williams KJ; Beltran AM; Cohn JN
    Am Heart J; 1994 Feb; 127(2):392-9. PubMed ID: 8296708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and hormonal actions of adrenomedullin.
    Nicholls MG
    Braz J Med Biol Res; 2004 Aug; 37(8):1247-53. PubMed ID: 15273827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide for the treatment of congestive heart failure.
    Schreiner GF; Protter AA
    Curr Opin Pharmacol; 2002 Apr; 2(2):142-7. PubMed ID: 11950624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide in patients with severe heart failure.
    Riegger AJ; Kromer EP; Kochsiek K
    Klin Wochenschr; 1986; 64 Suppl 6():89-92. PubMed ID: 2948071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma levels of adrenomedullin in patients with heart failure.
    Nishikimi T; Saito Y; Kitamura K; Ishimitsu T; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H
    J Am Coll Cardiol; 1995 Nov; 26(6):1424-31. PubMed ID: 7594065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term intravenous administration of adrenomedullin (AM) plus hANP therapy in acute decompensated heart failure: a pilot study.
    Nishikimi T; Karasawa T; Inaba C; Ishimura K; Tadokoro K; Koshikawa S; Yoshihara F; Nagaya N; Sakio H; Kangawa K; Matsuoka H
    Circ J; 2009 May; 73(5):892-8. PubMed ID: 19346663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nesiritide: the latest drug for treating heart failure.
    Fontana D
    Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure.
    Nagaya N; Satoh T; Nishikimi T; Uematsu M; Furuichi S; Sakamaki F; Oya H; Kyotani S; Nakanishi N; Goto Y; Masuda Y; Miyatake K; Kangawa K
    Circulation; 2000 Feb; 101(5):498-503. PubMed ID: 10662746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levels of adrenomedullin in plasma of patients with chronic congestive heart failure].
    Halawa B; Mazurek W
    Pol Arch Med Wewn; 1998 Jan; 99(1):2-8. PubMed ID: 9686497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to use nesiritide in treating decompensated heart failure.
    Mills RM; Hobbs RE
    Cleve Clin J Med; 2002 Mar; 69(3):252-6. PubMed ID: 11890216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nesiritide for the treatment of decompensated heart failure.
    Colucci WS
    J Card Fail; 2001 Mar; 7(1):92-100. PubMed ID: 11264555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The atrial natriuretic factor in severe congestive heart failure. Plasma level, hemodynamic, hormonal and renal effects].
    Riegger AJ; Kromer EP; Kochsiek K
    Dtsch Med Wochenschr; 1985 Oct; 110(42):1607-10. PubMed ID: 2931268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nesiritide for decompensated congestive heart failure.
    Med Lett Drugs Ther; 2001 Nov; 43(1118):100-1. PubMed ID: 11707752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic application of atrial natriuretic peptide for congestive heart failure].
    Harada M; Nakao K
    Nihon Rinsho; 2007 May; 65 Suppl 5():115-9. PubMed ID: 17571375
    [No Abstract]   [Full Text] [Related]  

  • 17. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.
    Lilleberg J; Laine M; Palkama T; Kivikko M; Pohjanjousi P; Kupari M
    Eur J Heart Fail; 2007 Jan; 9(1):75-82. PubMed ID: 16829185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide: from bench to bedside.
    Adams KF; Mathur VS; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.